SBC Medical Group (NASDAQ:SBC) Shares Down 0.3% – Should You Sell?

Shares of SBC Medical Group Holdings Incorporated (NASDAQ:SBC) were down 0.3% during trading on Friday . The company traded as low as $2.90 and last traded at $2.97. Approximately 74,097 shares were traded during mid-day trading, a decline of 49% from the average daily volume of 145,108 shares. The stock had previously closed at $2.98.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the stock. Wall Street Zen upgraded shares of SBC Medical Group to a “hold” rating in a research report on Saturday, May 9th. Weiss Ratings cut shares of SBC Medical Group from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Friday, May 22nd. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $8.50.

SBC Medical Group Stock Down 0.3%

The business has a fifty day moving average of $3.09 and a 200 day moving average of $3.79. The company has a quick ratio of 3.78, a current ratio of 3.82 and a debt-to-equity ratio of 0.12. The firm has a market cap of $304.66 million, a P/E ratio of 7.62 and a beta of 0.60.

SBC Medical Group (NASDAQ:SBC) last posted its earnings results on Thursday, May 14th. The company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.10 by $0.01. The company had revenue of $43.06 million during the quarter, compared to analyst estimates of $41.66 million. SBC Medical Group had a return on equity of 15.90% and a net margin of 24.09%. On average, equities research analysts predict that SBC Medical Group Holdings Incorporated will post 0.47 EPS for the current year.

Insiders Place Their Bets

In other news, CEO Yoshiyuki Aikawa sold 465,000 shares of SBC Medical Group stock in a transaction on Tuesday, April 28th. The shares were sold at an average price of $3.02, for a total transaction of $1,404,300.00. Following the transaction, the chief executive officer directly owned 78,839,460 shares of the company’s stock, valued at $238,095,169.20. This trade represents a 0.59% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 81.70% of the company’s stock.

Institutional Trading of SBC Medical Group

Several hedge funds have recently added to or reduced their stakes in the business. Geode Capital Management LLC acquired a new position in SBC Medical Group in the second quarter valued at about $455,000. XTX Topco Ltd acquired a new stake in shares of SBC Medical Group during the second quarter worth about $64,000. New York State Common Retirement Fund acquired a new stake in shares of SBC Medical Group during the second quarter worth about $104,000. Millennium Management LLC bought a new position in shares of SBC Medical Group during the 3rd quarter valued at about $219,000. Finally, Williams & Novak LLC acquired a new position in shares of SBC Medical Group in the 4th quarter valued at approximately $65,000. Institutional investors and hedge funds own 60.82% of the company’s stock.

SBC Medical Group Company Profile

SBC Medical Group, Inc is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.

The company’s primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services.